No Data
JonesTrading Initiates Prime Medicine(PRME.US) With Buy Rating, Announces Target Price $14
JonesTrading analyst Soumit Roy initiates coverage on $Prime Medicine(PRME.US)$ with a buy rating, and sets the target price at $14.According to TipRanks data, the analyst has a success rate of 23.5%
Prime Medicine (NASDAQ:PRME) Will Have To Spend Its Cash Wisely
Prime Medicine to Participate in Upcoming Investor Conferences
Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and Prime Medicine, Inc. (PRME)
HC Wainwright & Co. Reiterates Buy on Prime Medicine, Maintains $10 Price Target
Prime Medicine Analyst Ratings